BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17663789)

  • 1. Characterization of a negative transcriptional element in the BRCA1 promoter.
    MacDonald G; Stramwasser M; Mueller CR
    Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
    Antonova L; Mueller CR
    Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element.
    Atlas E; Stramwasser M; Mueller CR
    Oncogene; 2001 Oct; 20(48):7110-4. PubMed ID: 11704836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter.
    Atlas E; Stramwasser M; Whiskin K; Mueller CR
    Oncogene; 2000 Apr; 19(15):1933-40. PubMed ID: 10773883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of nephrin gene by the Ets transcription factor, GA-binding protein.
    Ristola M; Arpiainen S; Shimokawa T; Ra C; Tienari J; Saleem MA; Holthöfer H; Lehtonen S
    Nephrol Dial Transplant; 2013 Apr; 28(4):846-55. PubMed ID: 23197680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex.
    Thompson C; MacDonald G; Mueller CR
    Mol Cancer; 2011 May; 10():62. PubMed ID: 21609478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
    Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
    Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
    Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
    Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functional elements in the murine Gabp alpha/ATP synthase coupling factor 6 bi-directional promoter.
    Patton J; Block S; Coombs C; Martin ME
    Gene; 2006 Mar; 369():35-44. PubMed ID: 16309857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.
    Ritter HD; Antonova L; Mueller CR
    Mol Cancer Res; 2012 Apr; 10(4):558-69. PubMed ID: 22328717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
    Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
    Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Hockings JK; Degner SC; Morgan SS; Kemp MQ; Romagnolo DF
    Breast Cancer Res; 2008; 10(2):R29. PubMed ID: 18377656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F6 negatively regulates ultraviolet-induced apoptosis via modulation of BRCA1.
    Yang WW; Wang ZH; Zhu Y; Yang HT
    Cell Death Differ; 2007 Apr; 14(4):807-17. PubMed ID: 17096023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.
    Maor S; Papa MZ; Yarden RI; Friedman E; Lerenthal Y; Lee SW; Mayer D; Werner H
    Horm Metab Res; 2007 Mar; 39(3):179-85. PubMed ID: 17373631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.